Neurology Market Research Reports & Industry Analysis

According to our (Global Info Research) latest study, the global Neuroscience market size was valued at US$ 28090 million in 2024 and is forecast to a readjusted size of USD 35910 million by 2031 with...

The global implantable neurostimulators market is valued at approximately USD 5.00 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 202...

The global artificial intelligence (AI) in neurology operating room market size reached USD 63.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,297 Million by 2033, ex...

... in the neurovascular devices/interventional neurology market Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various neurovascular devices/interventional neurology products across geographies Market Diversification: Exhaustive ...

... growing demand for neurovascular intervention device due to increase in aging population and decreasing the cost of neurovascular products. The Neurovascular Intervention devices market is a consolidated, highly competitive market and all ...

... Asia-Pacific Neurology Software market. Chapter 1, to describe Neurology Software Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Neurology Software ...

... Europe Neurology Software market. Chapter 1, to describe Neurology Software Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Neurology Software ...

... dominant region in the global Neurovascular Devices market in 2015. Asia-Pacific would witness promising CAGR during the forecast period (2016-2022). The report covers the analysis of key stake holders of the Neurovascular Devices market. Key companies profiled in the ...

... Asia-Pacific Neurovascular Devices market is segmented into China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia-Pacific. China remained the dominant Country in the Asia-Pacific Neurovascular Devices market ...

... Europe Neurovascular Devices market is segmented into Germany, UK, France, Russia, Spain, Italy and Rest of Europe. Germany remained the dominant Country in the Europe Neurovascular Devices market ...

... LAMEA Neurovascular Devices market is segmented into Brazil, ARGENTINA, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA. Brazil remained the dominant Country in the LAMEA Neurovascular Devices market ...

... . Neurothrombectomy Devices is further segmented into Clot Retrievers, Suction & Aspiration Devices and Snares. Based on Country, North America Neurovascular Devices market is segmented into US, Canada, Mexico and Rest of North America. US remained the dominant Country in the North America Neurovascular Devices market in 2015 ...

... MARKET INSIGHTS: The Global Central Nervous System (CNS) Biomarkers Market is expected to grow at a CAGR 18% during 2015-2020. The Global CNS Biomarkers Market is growing ... at a modest rate due to development in imaging system, proteomics & genomics ...

... such popular technique is interventional neurology. This technique provides a cost effective alternative for traditional neurosurgery. According to RNCOS new release, “Global Interventional Neurology Market Outlook to 2020”, the industry is expanding at a fast pace. The study has been done comprehensively including factors affecting growth, latest innovations, market ...

... minimally invasive neurological and faster acting stimulation devices that attract higher market usage and penetration in the neurology devices market. Neurosurgery segment ... over the forecast period. Key participants of the neurology devices market include Johnson and Johnson, B.Braun Melsungen AG, Boston ...

... collectively as the ABCRs), which for many years were positioned as the gold standard therapies of choice - see Physician Views Poll Results – Neurologists ... analysts, which Novartis and Sanofi will no doubt do their best to rectify. Analysts at Barclays recently noted that 'importantly, the multiple sclerosis ...

... Sanofi securing European approval for its multiple sclerosis ... therapies (Gilenya, Aubagio and Tecfidera – yet to launch in Europe) providing comparable efficacy with greater convenience, there is ... patients using the drug developing PML. This week's Physician Views poll will ask neurologists based in the 5EU ( ...

... neurovascular industry. The major companies operating in this market include Stryker, Medtronic, Covidien (Ev3) and Johnson & Johnson (Micrus). The report titled “Global Neurovascular Market: Trends & Opportunities (2013-18)” provides a detailed insight into the neurovascular market. The report analyzes the primary segments of neurovascular disorders and the ...

... continue to be the largest segment in the neurostimulation devices market over the forecast period (2012 to 2017). 3. Deep Brain Stimulation (DBS) segment ... companies. It also contains a SWOT analysis and detailed profile of leading devices within this segment. We have looked at both the existing commercial ...